The fungal exopolysaccharide galactosaminogalactan mediates virulence by enhancing resistance to neutrophil extracellular traps MJ Lee, H Liu, BM Barker, BD Snarr, FN Gravelat, Q Al Abdallah, ... PLoS pathogens 11 (10), e1005187, 2015 | 176 | 2015 |
Microbial glycoside hydrolases as antibiofilm agents with cross-kingdom activity BD Snarr, P Baker, NC Bamford, Y Sato, H Liu, M Lehoux, FN Gravelat, ... Proceedings of the National Academy of Sciences 114 (27), 7124-7129, 2017 | 97 | 2017 |
Galectin-3 enhances neutrophil motility and extravasation into the airways during Aspergillus fumigatus infection BD Snarr, G St-Pierre, B Ralph, M Lehoux, Y Sato, A Rancourt, ... PLoS pathogens 16 (8), e1008741, 2020 | 48 | 2020 |
Posaconazole-loaded leukocytes as a novel treatment strategy targeting invasive pulmonary aspergillosis SR Baistrocchi, MJ Lee, M Lehoux, B Ralph, BD Snarr, R Robitaille, ... The Journal of infectious diseases 215 (11), 1734-1741, 2017 | 40 | 2017 |
Beyond tissue concentrations: antifungal penetration at the site of infection Y Zhao, B Prideaux, S Baistrocchi, DC Sheppard, DS Perlin Medical mycology 57 (Supplement_2), S161-S167, 2019 | 18 | 2019 |
Transfusable neutrophil progenitors as cellular therapy for the prevention of invasive fungal infections DB Sykes, MM Martinelli, P Negoro, S Xu, K Maxcy, K Timmer, AL Viens, ... Journal of leukocyte biology 111 (6), 1133-1145, 2022 | 9 | 2022 |
Supervised exercise for cardiovascular rehabilitation—the Limerick programme R O’Connor, R Power, K Bissett, KA Bourdan, K Togher, H Power, ... Irish Journal of Medical Science (1971-) 189, 403-404, 2020 | 1 | 2020 |
In vivo pharmacokinetics and pharmacodynamics of posaconazole in a mouse model of invasive aspergillosis SR Baistrocchi, H Liu, RJM Bruggeman, WW Hope, S Filler, DC Sheppard MYCOSES 60, 221-222, 2017 | 1 | 2017 |
Strategies to Optimize the Effectiveness of Antifungal Treatment for Invasive Aspergillosis D Sheppard, J Fricker, S Baistrocchi Anti-Infective Agents 15 (1), 20-24, 2017 | | 2017 |